GAMB vs JMG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 2/9 and a technical trend score of 0/100. While the company maintains impressive gross margins (90.78%) and strong revenue growth (31%), these are overshadowed by a severe collapse in earnings and a 70.6% one-year price decline. The stock is currently trading near its 52-week low, and despite a 'strong buy' analyst consensus, the recent quarterly earnings miss (-588.9% surprise) suggests a fundamental disconnect between analyst expectations and operational reality.
JMG presents a stark contrast between explosive operational growth and a precarious balance sheet. While the Piotroski F-Score of 6/9 indicates stable financial health and earnings growth is exceptional at 227.10%, the company exhibits a critical red flag with a Price/Book ratio of -35.00, signaling negative shareholders' equity. The current price of $6.61 trades at a significant premium to the growth-based intrinsic value of $4.42. Consequently, the strong top and bottom-line momentum is heavily offset by liquidity risks and a fragile capital structure.
Compare Another Pair
Related Comparisons
GAMB vs JMG: Head-to-Head Comparison
This page compares Gambling.com Group Limited (GAMB) and JM Group Limited (JMG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.